239 related articles for article (PubMed ID: 35159191)
1. Targeting the gp130/STAT3 Axis Attenuates Tumor Microenvironment Mediated Chemoresistance in Group 3 Medulloblastoma Cells.
Sreenivasan L; Li LV; Leclair P; Lim CJ
Cells; 2022 Jan; 11(3):. PubMed ID: 35159191
[TBL] [Abstract][Full Text] [Related]
2. Autocrine IL-6/STAT3 signaling aids development of acquired drug resistance in Group 3 medulloblastoma.
Sreenivasan L; Wang H; Yap SQ; Leclair P; Tam A; Lim CJ
Cell Death Dis; 2020 Dec; 11(12):1035. PubMed ID: 33279931
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
[TBL] [Abstract][Full Text] [Related]
4. p42/p44-MAPK and PI3K are sufficient for IL-6 family cytokines/gp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAK/STAT activation.
Fahmi A; Smart N; Punn A; Jabr R; Marber M; Heads R
Cell Signal; 2013 Apr; 25(4):898-909. PubMed ID: 23268184
[TBL] [Abstract][Full Text] [Related]
5. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
Chen J; Zhang Y; Petrus MN; Xiao W; Nicolae A; Raffeld M; Pittaluga S; Bamford RN; Nakagawa M; Ouyang ST; Epstein AL; Kadin ME; Del Mistro A; Woessner R; Jaffe ES; Waldmann TA
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3975-3980. PubMed ID: 28356514
[TBL] [Abstract][Full Text] [Related]
6. STAT3 can be activated through paracrine signaling in breast epithelial cells.
Lieblein JC; Ball S; Hutzen B; Sasser AK; Lin HJ; Huang TH; Hall BM; Lin J
BMC Cancer; 2008 Oct; 8():302. PubMed ID: 18939993
[TBL] [Abstract][Full Text] [Related]
7. TRAF2 and TRAF5 associated with the signal transducing receptor gp130 limit IL-6-driven transphosphorylation of JAK1 through the inhibition of proximal JAK-JAK interaction.
Kimura M; Nagashima H; Okuyama Y; Ishii N; So T
Int Immunol; 2018 Jun; 30(7):291-299. PubMed ID: 29668931
[TBL] [Abstract][Full Text] [Related]
8. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
[TBL] [Abstract][Full Text] [Related]
9. gp130 Cytokines Activate Novel Signaling Pathways and Alter Bone Dissemination in ER+ Breast Cancer Cells.
Omokehinde T; Jotte A; Johnson RW
J Bone Miner Res; 2022 Feb; 37(2):185-201. PubMed ID: 34477239
[TBL] [Abstract][Full Text] [Related]
10. The inhibition of N-glycosylation of glycoprotein 130 molecule abolishes STAT3 activation by IL-6 family cytokines in cultured cardiac myocytes.
Matsuo R; Morihara H; Mohri T; Murasawa S; Takewaki K; Nakayama H; Maeda M; Fujio Y
PLoS One; 2014; 9(10):e111097. PubMed ID: 25340554
[TBL] [Abstract][Full Text] [Related]
11. Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis.
Fischer P; Hilfiker-Kleiner D
Basic Res Cardiol; 2007 Jul; 102(4):279-97. PubMed ID: 17530315
[TBL] [Abstract][Full Text] [Related]
12. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes.
Kunisada K; Hirota H; Fujio Y; Matsui H; Tani Y; Yamauchi-Takihara K; Kishimoto T
Circulation; 1996 Nov; 94(10):2626-32. PubMed ID: 8921810
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection of interleukin-6 against NMDA-induced neurotoxicity is mediated by JAK/STAT3, MAPK/ERK, and PI3K/AKT signaling pathways.
Fang XX; Jiang XL; Han XH; Peng YP; Qiu YH
Cell Mol Neurobiol; 2013 Mar; 33(2):241-51. PubMed ID: 23161148
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory Mechanism of the Outer Membrane Growth of Chronic Subdural Hematomas.
Osuka K; Watanabe Y; Usuda N; Aoyama M; Iwami K; Takeuchi M; Watabe T; Takayasu M
J Neurotrauma; 2017 Jun; 34(11):1996-2000. PubMed ID: 28027695
[TBL] [Abstract][Full Text] [Related]
15. Activated Rac1 requires gp130 for Stat3 activation, cell proliferation and migration.
Arulanandam R; Geletu M; Feracci H; Raptis L
Exp Cell Res; 2010 Mar; 316(5):875-86. PubMed ID: 19852956
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin-M-Reactive Pericytes Aggravate Blood-Brain Barrier Dysfunction by Activating JAK/STAT3 Signaling In Vitro.
Takata F; Dohgu S; Sakaguchi S; Sakai K; Yamanaka G; Iwao T; Matsumoto J; Kimura I; Sezaki Y; Tanaka Y; Yamauchi A; Kataoka Y
Neuroscience; 2019 Dec; 422():12-20. PubMed ID: 31705893
[TBL] [Abstract][Full Text] [Related]
17. The tyrosine phosphatase SHP2 increases robustness and information transfer within IL-6-induced JAK/STAT signalling.
Fiebelkow J; Guendel A; Guendel B; Mehwald N; Jetka T; Komorowski M; Waldherr S; Schaper F; Dittrich A
Cell Commun Signal; 2021 Sep; 19(1):94. PubMed ID: 34530865
[TBL] [Abstract][Full Text] [Related]
18. Blocking gp130 signaling suppresses autotaxin expression in adipocytes and improves insulin sensitivity in diet-induced obesity.
Sun S; Wang R; Song J; Guan M; Li N; Zhang X; Zhao Z; Zhang J
J Lipid Res; 2017 Nov; 58(11):2102-2113. PubMed ID: 28874440
[TBL] [Abstract][Full Text] [Related]
19. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
[TBL] [Abstract][Full Text] [Related]
20. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
Podewski EK; Hilfiker-Kleiner D; Hilfiker A; Morawietz H; Lichtenberg A; Wollert KC; Drexler H
Circulation; 2003 Feb; 107(6):798-802. PubMed ID: 12591746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
